Physicians Charged in the $2 Billion L.A. Health Care Fraud Takedown: What Florida Doctors Should Know

Federal prosecutors in Los Angeles charged 15 people on October 22 in health care fraud schemes the government says generated $2 billion in false claims, and six of them are licensed medical professionals. A cardiothoracic surgeon. A chiropractor accused of posing as a doctor. Two physicians who signed genetic test orders. An 83-year-old hospice medical director. A physician accused of selling drug samples. If you are a Florida physician who signs orders, certifications or medical director paperwork for a business you do not own, read this case as if it had been filed in Miami.

Fifteen people charged in Los Angeles on October 22, 2026. Six are licensed medical professionals.

Key Takeaways

• Six of the 15 defendants charged in Los Angeles on October 22, 2026 are licensed medical professionals, including a surgeon and a hospice medical director.
• Health care fraud under 18 U.S.C. § 1347 carries 10 years per count, rising to 20 when a patient suffers serious bodily injury.
• Florida treats payments for lab referrals as patient brokering under Fla. Stat. §§ 456.054 and 817.505, on top of the federal Anti-Kickback Statute.
• Defendants charged in Los Angeles appeared in Texas and Illinois, so a physician practicing in the Southern District of Florida can be charged in California.

What the Los Angeles Takedown Charged

The schemes fall into six groups:

• Sham addiction treatment. A father and son allegedly controlled dozens of sham treatment companies that billed private insurers more than $1.6 billion, recruiting patients with flights, cash, housing and drugs. A facility manager has pleaded guilty.
• Unnecessary atherectomies. A surgeon and his chiropractor partner are charged over about $135 million billed to Medicare for invasive artery procedures, some on patients the government says had no arterial disease.
• Hospice. Three cases target a hospice operator, a medical director accused of certifying patients who were not terminally ill, and an operator of four hospices run through nominee owners.
• Kickbacks. Two physicians allegedly took per-patient payments from a lab marketer for signing genetic test orders, and a referral source has agreed to plead guilty to taking rehab kickbacks disguised as marketing fees.
• Medi-Cal pharmacy billing. One defendant allegedly exploited a pause in Medi-Cal's prior authorization rules to bill about $269 million.
• Drug samples. A physician is charged with selling samples of Ozempic, Mounjaro and Rybelsus to pharmacy owners who repackaged and dispensed them.

Two defendants made first appearances in the Northern District of Texas and one in the Northern District of Illinois. These are allegations, and every defendant is presumed innocent.

What the Government Is Building: Cases That Run Through a License

Each licensed defendant allegedly supplied something the scheme could not run without: procedures, terminal-illness certifications, test orders, manufacturer samples. Without the clinician, the claims do not pay. That is why prosecutors charge the clinician. An owner can find another marketer. The scheme needs the license.

"An owner can find another marketer. The scheme needs the license."— Aaron M. Cohen, AMC Defense Law

Detection follows the same logic. The press release says data analytics flagged the surgeon as an extreme national outlier in atherectomy billing. The lead hospice operator's patients left hospice alive at more than four times the national rate. The pharmacy scheme grew in a gap opened by a program transition. Each left a signature in the claims data. The 2026 National Health Care Fraud Takedown in June charged 455 defendants, 90 of them doctors and other licensed professionals, on the same data-first method. Now it is running district by district.

Outlier atherectomy billing. Hospice patients discharged alive at four times the national rate. Each scheme left a signature in the claims data.

On April 7, 2026, the Justice Department created a National Fraud Enforcement Division that took over the Criminal Division's Health Care Fraud Unit, and its trial attorneys are prosecuting several of the Los Angeles cases. Florida physicians should assume the same playbook is running in the Southern and Middle Districts of Florida.

Exposure and Charges for Physicians

Florida law reaches this conduct before any federal statute does. Fla. Stat. § 456.054 bars health care providers from paying or receiving kickbacks for referrals and specifically prohibits paying for referrals to clinical laboratories. Violations are punished as patient brokering under Fla. Stat. § 817.505, a third-degree felony that becomes a first-degree felony with a $500,000 fine when 20 or more patients are involved.

The federal counts stack on top.

Allegations of patient harm put those tiers in play. Conspiracy under 18 U.S.C. § 1349 carries the same maximum. The genetic testing fraud defendants are charged with conspiring under 18 U.S.C. § 371 to violate the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), which carries 10 years per violation. Recovery-industry kickbacks fall under EKRA, 18 U.S.C. § 220, which reaches private insurance. Selling drug samples violates 21 U.S.C. § 353(c)(1) and carries up to 10 years under 21 U.S.C. § 333(b)(1).

Sentencing Exposure and the Medical License

At sentencing, loss drives the number. The Sentencing Guidelines treat the total billed to a government health care program as prima facie evidence of intended loss and add levels once program losses pass $1 million. Physicians also routinely face a two-level increase under U.S.S.G. § 3B1.3 for abusing a position of trust or using a special skill. A loss amount dispute is often the most valuable fight in the case.

Then the license. A health care fraud conviction triggers mandatory exclusion from Medicare and Medicaid under 42 U.S.C. § 1320a-7 for at least five years, and Fla. Stat. § 456.0635 requires the state to refuse to renew the license of anyone on the federal exclusion list. For most physicians, that ends the practice regardless of the sentence.

Mistakes Physicians Make Before They Call a Lawyer

• Assuming you are a witness. An agent who interviews a medical director or ordering physician is usually interviewing a subject. A friendly explanation becomes intent evidence or a false-statement count under 18 U.S.C. § 1001.
• Trusting the paperwork. In the rehab case, kickbacks were papered as marketing services under a contract the government calls a sham. A medical director or consulting agreement does not protect payments that track referral volume.
• Sharing the company's lawyer. The owner's counsel represents the owner. When the government wants a cooperator, physician and owner rarely stay on the same side.
• Producing charts without a plan. Records produced in response to a federal grand jury subpoena are the evidence. Production needs privileged review and a litigation hold.
• Continuing to sign. Every certification or order signed after the business receives a subpoena makes the intent case easier.

Records produced in response to a federal grand jury subpoena are the evidence. Production needs privileged review and a litigation hold.

A Strategic Defense for a Physician Under Investigation

Federal investigation defense starts with independent counsel retained before any interview, and with an early look at the medicine. Most physician cases turn on medical necessity and knowledge. A privileged chart review with a qualified clinical expert tells you whether the government's data theory survives the patient files. Outlier billing sometimes has a clinical explanation. You need to know whether yours does before the prosecutor decides.

Read the charging documents in this takedown. At least four of the 15 defendants were charged by information rather than indictment. A felony information requires a waiver of indictment under Federal Rule of Criminal Procedure 7(b), which usually reflects a resolution negotiated before the case became public. That is pre-charge negotiation with the AUSA at work, and it rewards people who engage early.

Why the Window Is Closing

The pharmacy defendant was charged by complaint in June and is now charged by indictment. The data flags, subpoenas and staff interviews came long before either. That earlier stretch decides whether a physician is treated as a witness or a subject, whether a matter resolves civilly, and how narrow any charges are.

The signals are plain: one fraud division since April, 90 licensed professionals charged in June, and licensed professionals charged today in four of six categories. If you sign hospice certifications, genetic test orders or procedure notes for someone else's business, or you have received a subpoena, a target letter or a call from an agent, the time to bring in a federal criminal defense attorney is before the next press release.

Common Questions

Facing a Federal Health Care Fraud Investigation as a Florida Physician?

AMC Defense Law represents physicians, medical directors, clinic owners and other licensed professionals in federal health care fraud investigations and prosecutions across Florida and nationwide, with a focus on South Florida healthcare fraud defense. If you have received a subpoena, a target letter or a request for patient records, a confidential consultation with a white collar defense attorney can help you understand your exposure while charging decisions are still open. Contact AMC Defense Law in Boca Raton at 561-542-5494 or amc@amcdefenselaw.com.

If you or your loved ones have been arrested or are under federal investigation for health care fraud, call Aaron M. Cohen, 24 hours a day to get help.

Aaron M. Cohen, AMC Defense Law

About the author. Aaron M. Cohen is the founder and principal attorney of AMC Defense Law, a criminal defense firm in Boca Raton, Florida, with more than 30 years of experience in state and federal courts. He is admitted to practice in Florida, New York, New Jersey, and the District of Columbia, and before the United States District Courts for the Southern and Middle Districts of Florida, the Southern, Eastern, and Western Districts of New York, the District of New Jersey, and the Northern District of Texas. He appears pro hac vice in other federal districts nationwide. The firm represents clients in federal investigations and prosecutions involving healthcare fraud, Anti-Kickback Statute matters, DME and telemedicine fraud, peptide and compounded-drug enforcement, controlled-substance and drug conspiracy cases, financial crimes, and complex federal litigation, in Florida and nationwide.

This article is provided for general informational purposes only and does not constitute legal advice. Reading it does not create an attorney-client relationship. Every case is different, and outcomes depend on specific facts. The charges described above are allegations, and every defendant is presumed innocent unless and until proven guilty beyond a reasonable doubt. If you are under investigation or facing charges, consult a qualified attorney about your situation.